1.0 2026-04-05 13:16:24 UTC 2026-08-21 19:32:21 UTC N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine SmallMolecule N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine belongs to the aminoquinolines and derivatives, a subclass of quinolines and derivatives within the organic compounds. This organoheterocyclic compound has the formula C21H27N5 and an average molecular weight of 349.48 g/mol. It acts as an inhibitor and antagonist of the C-X-C chemokine receptor type 4 (CXCR4). The compound is recorded as being used in healthcare, pharmaceuticals, and veterinary products as an immunostimulant, with oral exposure being the recorded route. C21H27N5 349.482 349.2266459 558447-26-0 [H][C@@]1(CCCC2=C1N=CC=C2)N(CCCCN)CC1=NC2=CC=CC=C2N1 InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1 WVLHHLRVNDMIAR-IBGZPJMESA-N Detected and Not Quantified logp 2.61 average_mass 349.482 ChemAxon mono_mass 349.2266459 ChemAxon smiles [H][C@@]1(CCCC2=C1N=CC=C2)N(CCCCN)CC1=NC2=CC=CC=C2N1 ChemAxon formula C21H27N5 ChemAxon inchi InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1 ChemAxon inchikey WVLHHLRVNDMIAR-IBGZPJMESA-N ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f3bf31278a8> DB05501 11256587 BE0000919